Diagnostic and prognostic implications of myocardial Gremlin-1 expression in patients with structural myocardial disease

DSpace Repository


Dateien:

URI: http://hdl.handle.net/10900/69412
http://nbn-resolving.de/urn:nbn:de:bsz:21-dspace-694121
http://dx.doi.org/10.15496/publikation-10827
http://nbn-resolving.org/urn:nbn:de:bsz:21-dspace-694126
http://nbn-resolving.org/urn:nbn:de:bsz:21-dspace-694126
Dokumentart: PhDThesis
Date: 2016
Language: English
Faculty: 4 Medizinische Fakultät
4 Medizinische Fakultät
Department: Medizin
Advisor: Geisler, Tobias (Prof. Dr.)
Day of Oral Examination: 2016-03-22
DDC Classifikation: 610 - Medicine and health
Keywords: Herzkrankheit
License: http://tobias-lib.uni-tuebingen.de/doku/lic_mit_pod.php?la=de http://tobias-lib.uni-tuebingen.de/doku/lic_mit_pod.php?la=en
Order a printed copy: Print-on-Demand
Show full item record

Abstract:

Gremlin-1, an antagonist of bone morphogenetic proteins, is involved in fibrotic tissue formation in kidney, lung and liver. The impact of myocardial Gremlin-1 expression is unknown. Therefore, we investigated the diagnostic and prognostic value of Gremlin-1 in structural myocardial diseases.

This item appears in the following Collection(s)